Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like 3 Hottest Areas of Drug Development to Keep an Eye on in 2018 December 19, 2017 Another Biotech Bites the Dust as Cambridge's Raze Shuts Down December 13, 2017 Ohr Pharma Suspends Work at San Diego Lab February 23, 2017